Articles by Rita Peters - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Rita Peters

US Biopharma Worries About Losing Lead in Innovation

Changes are needed to maintain US biopharma innovation leadership.
May 2, 2014

Changes are needed to maintain US biopharma innovation leadership.

Publishing Beyond the Printed Page

Apr 2, 2014

More media options open publishing opportunities for drug development experts.

Defining Quality Metrics is No Easy Task

ISPE and PDA take on the challenge of recommending quality metrics.
Feb 2, 2014

ISPE and PDA take on the challenge of recommending quality metrics.

2014 Manufacturing Trends and Outlook

Single-use systems and other technologies drive process efficiencies, but there is room for improvement.
Jan 15, 2014

A survey of BioPharm International readers found that single-use systems and other technologies are driving process efficiencies in biomanufacturing, but there is room for improvement.

New Dynamics in Drug Pricing and Prescribing

Jan 3, 2014

Generics, market dynamics, and global demand are changing drug-spending patterns.

Drugs At What Cost

Jan 2, 2014

Generics, market dynamics, and global demand are changing drug spending patterns.

Uncertainty in the Workplace

Industry mergers, acquisitions and downsizing contribute to uncertainty in job security.
Dec 2, 2013

Industry mergers, acquisitions and downsizing contribute to uncertainty in job security in the European bio/pharmaceutical market.

Industry Optimism Outweighs Personal Job Security

Restructuring mutes employment optimism.
Dec 2, 2013

Pharmaceutical Technology's 2013 Employment Survey reveals some optimism for the industry's future performance, but ongoing concerns about individual job prospects.

New Funding and Approval Pathways Prove Popular

The JOBS Act and FDASIA show early signs of accelerating drug development.
Nov 2, 2013

The JOBS Act and FDASIA show early signs of accelerating drug development.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here